253873-06-2

Basic information

• Product Name: Carbamic acid, [[1,4-bis(phenylmethyl)-2-piperazinyl]methyl]-, 1-methylethyl ester
• CAS NO: 253873-06-2
• Molecular Formula: C23H31N3O2
• Molecular Weight: 381.518
• Mol File: 253873-06-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [[1,4-bis(phenylmethyl)-2-piperazinyl]methyl]-, 1-methylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [[1,4-bis(phenylmethyl)-2-piperazinyl]methyl]-, 1-methylethyl ester(253873-06-2)
• EPA Substance Registry System: Carbamic acid, [[1,4-bis(phenylmethyl)-2-piperazinyl]methyl]-, 1-methylethyl ester(253873-06-2)

Safety Data

• Hazardous Substances Data: 253873-06-2(Hazardous Substances Data)

Upstream product

• 170701-81-2 1,4-dibenzyl-2-piperazinecarbonitrile 
• 108-23-6 isopropyl chloroformate 
• 116163-33-8 2-aminomethyl-1,4-di-phenylmethyl piperazine 

Downstream Products

• 253873-09-5 1,4-bis(3',4',5'-trimethoxybenzoyl)-2-(isopropyloxycarbonylaminomethyl)piperazine 

Relevant articles and documents

Structure-activity relationships in platelet-activating factor. 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity

The HIV-1 central nervous system infection leads to the onset of neurological impairments called AIDS dementia complex (ADC). PAF plays an important role in this pathology, as it is an HIV-1-induced neurotoxin produced by infected or activated macrophages